Last reviewed · How we verify
BC-819
At a glance
| Generic name | BC-819 |
|---|---|
| Also known as | DTA-H19 |
| Sponsor | Anchiano Therapeutics Israel Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BC-819 CI brief — competitive landscape report
- BC-819 updates RSS · CI watch RSS
- Anchiano Therapeutics Israel Ltd. portfolio CI